Autism Originates in the Womb, Explains Hyderabad Expert

Rapid Summary:

• Dr. T. Chandrasekhar, cardiologist and founder of Resplice Institute, held a press conference in Vijayawada discussing autism and related neurological conditions.
• He emphasized that autism starts during pregnancy, influenced by factors in the womb environment such as toxins crossing the placental barrier and affecting neural advancement.
• Resplice Institute uses therapies like Faecal Microbiota Transplantation (FMT) and multi-omics-based personalized treatments to address gut-brain axis issues central to modern disorders, including autism.
• The institute will organize a free camp on September 14, 2025, at Icon Public School in Vijayawada to raise awareness about FMT therapy for children with gut problems. contact for registration: Bhavani (9100065552).
• Dr. Chandrasekhar founded the institute after his own daughter’s experiences with severe gut health issues post-autism diagnosis at one year old; this led him to research microbiome science since 2017.
• The institute runs India’s first stool bank approved by ICMR clinical trials on FMT for autism and AI-integrated multi-omics diagnostics initiatives.
• Notable achievements: Author of Rebuilding from Root – Environment,Microbiome and Autism (2025),recipient of Atal Achievement Award & Global Healthcare Achievement Award.

Indian Opinion Analysis:

Dr. T.Chandrasekhar’s research highlights critical insights into how prenatal factors can influence neurological developments leading to autism spectrum disorders. By founding Resplice Institute based on personal experience with his daughter’s condition, he has placed emphasis on addressing gut health through innovative medical approaches like Faecal Microbiota Transplantation (FMT). This linkage between gut microbiomes and behavioral symptoms could open new avenues in treating developmental disorders more holistically.

The establishment of India’s first stool bank under ICMR-approved clinical trials signals progressive strides in integrating cutting-edge therapies like FMT into mainstream healthcare while championing evidence-based solutions targeting the complex interplay between genetics and environmental influences.

The upcoming camp planned by Resplice aims at public engagement-a pivotal step towards democratizing access to specialized care while spreading awareness among families affected by similar challenges across communities in India-perhaps helping destigmatize conditions like Autism Spectrum Disorder within society.

For further reading: Source